Form 4: Denali Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Peter Scott Chin, Chief Medical Officer of Denali Therapeutics Inc., sold 1,654 shares of common stock on September 4, 2026 for $22.29 per share.
Summary
- Open-market sale: disposed of 1,654 Common Stock at $22.29 ($36,868) on September 4, 2026; holds 204,538 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $36,868 of stock on the open market.
Insider Transactions
Peter Scott Chin — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | Common Stock | 1,654 | $22 | $36.9K | 204,538 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (1,654 shares) |
Keywords
insider transaction, Form 4, DNLI, Denali Therapeutics Inc., bearish, Peter Scott Chin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.